High Purity Pharmaceuticals Chemical Apis Trelagliptin Succinate
Product Description
Purity 99%min Trelagliptin Succinate CAS Steady Supply
SYR-472 s the world's first weekly oral DPP 4 Inhibitors, used in type 2 diabetes, this product is a weekly dipeptide base peptidase IV (DPP - 4) inhibitors, through selective, sustained suppression DPP - 4, control blood sugar levels. DPP - 4 is an enzyme that can cause intestinal insulin, glucagon like peptide 1 (glp-1) promote insulin and glucose dependence polypeptide (GIP) inactivation, and these two im down insulin plays an important role in regulating blood sugar. Inhibiting dd-4 can increase blood glucose levels dependent on insulin secretion, which can control blood glucose levels.
Generally, adults take orally SYR-472 100mg once a week.
Trelagliptin succinate is suitable for type 2 diabetes. It is a weekly dipeptidyl peptidase IV (DPP-4) inhibitor. It can control blood sugar levels by selectively
and continuously inhibiting DPP-4. DPP-4 is an enzyme that can trigger the inactivation of incretin (glucagon-like peptide-1 (GLP-1) and glucose-dependent
insulin-promoting polypeptide (GIP). It plays an important role in regulation. Inhibiting DPP-4 can increase blood glucose level-dependent insulin secretion,
thereby controlling blood glucose levels.
Trelagliptin succinate CAS 1029877-94-8
Grade Standard :Medicine Grade
Purity: 99%
Appearance : White Powder
Packing : 100G/Bag
Molecular Formula: C22H26FN5O6
Character： This product is soluble in dimethyl sulfoxide or water, slightly soluble in methanol, slightly soluble in absolute ethanol, very slightly soluble in acetonitrile, almost insoluble in methylene chloride
Kind :pharmaceutical raw materials
Industry: medicine
Area :Antihypertensive and hypoglycemic drugs
Related Products Troglitin Succinate Tablets
Product Categories : Trelagliptin Succinate